Shi L - Search Results

1

Rapamycin enhances the sensitivity of ER‑positive breast cancer cells to tamoxifen by upregulating p73 expression.

Zhu L, Li XX, Shi L, Wu J, Qian JY, Xia TS, Zhou WB, Sun X, Zhou XJ, Wei JF, Ding Q. Zhu L, et al. Among authors: shi l. Oncol Rep. 2019 Jan;41(1):455-464. doi: 10.3892/or.2018.6842. Epub 2018 Nov 1. Oncol Rep. 2019. PMID: 30542717

2

Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer.

Shi L, Dong B, Li Z, Lu Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Wang Z, Xie Y. Shi L, et al. J Clin Oncol. 2009 Jul 20;27(21):3423-9. doi: 10.1200/JCO.2008.17.2254. Epub 2009 Jun 1. J Clin Oncol. 2009. PMID: 19487384 Free PMC article.

3

The apoptotic effect of D Rhamnose β-hederin, a novel oleanane-type triterpenoid saponin on breast cancer cells.

Cheng L, Xia TS, Wang YF, Zhou W, Liang XQ, Xue JQ, Shi L, Wang Y, Ding Q. Cheng L, et al. Among authors: shi l. PLoS One. 2014 Mar 6;9(6):e90848. doi: 10.1371/journal.pone.0090848. eCollection 2014. PLoS One. 2014. PMID: 24603880 Free PMC article.

4

The anticancer effect and mechanism of α-hederin on breast cancer cells.

Cheng L, Xia TS, Wang YF, Zhou W, Liang XQ, Xue JQ, Shi L, Wang Y, Ding Q, Wang M. Cheng L, et al. Among authors: shi l. Int J Oncol. 2014 Aug;45(2):757-63. doi: 10.3892/ijo.2014.2449. Epub 2014 May 19. Int J Oncol. 2014. PMID: 24842044

5

RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer.

Xue JQ, Xia TS, Liang XQ, Zhou W, Cheng L, Shi L, Wang Y, Ding Q. Xue JQ, et al. Among authors: shi l. BMC Cancer. 2014 May 7;14:322. doi: 10.1186/1471-2407-14-322. BMC Cancer. 2014. PMID: 24884756 Free PMC article.

6

Estrogen receptor (ER) was regulated by RNPC1 stabilizing mRNA in ER positive breast cancer.

Shi L, Xia TS, Wei XL, Zhou W, Xue J, Cheng L, Lou P, Li C, Wang Y, Wei JF, Ding Q. Shi L, et al. Oncotarget. 2015 May 20;6(14):12264-78. doi: 10.18632/oncotarget.3654. Oncotarget. 2015. PMID: 25881544 Free PMC article.

7

RNPC1 enhances progesterone receptor functions by regulating its mRNA stability in breast cancer.

Lou P, Li C, Shi L, Xia TS, Zhou W, Wu J, Zhou X, Li X, Wang Y, Wei JF, Ding Q. Lou P, et al. Among authors: shi l. Oncotarget. 2017 Mar 7;8(10):16387-16400. doi: 10.18632/oncotarget.12016. Oncotarget. 2017. PMID: 27634883 Free PMC article.

8

The role of c-Myc-RBM38 loop in the growth suppression in breast cancer.

Li XX, Shi L, Zhou XJ, Wu J, Xia TS, Zhou WB, Sun X, Zhu L, Wei JF, Ding Q. Li XX, et al. Among authors: shi l. J Exp Clin Cancer Res. 2017 Apr 11;36(1):49. doi: 10.1186/s13046-017-0521-5. J Exp Clin Cancer Res. 2017. PMID: 28399911 Free PMC article.

9

Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis.

Sun X, Zhangyuan G, Shi L, Wang Y, Sun B, Ding Q. Sun X, et al. Among authors: shi l. Medicine (Baltimore). 2017 May;96(19):e6860. doi: 10.1097/MD.0000000000006860. Medicine (Baltimore). 2017. PMID: 28489780 Free PMC article. Review.

10

RBM38 is involved in TGF-β-induced epithelial-to-mesenchymal transition by stabilising zonula occludens-1 mRNA in breast cancer.

Wu J, Zhou XJ, Sun X, Xia TS, Li XX, Shi L, Zhu L, Zhou WB, Wei JF, Ding Q. Wu J, et al. Among authors: shi l. Br J Cancer. 2017 Aug 22;117(5):675-684. doi: 10.1038/bjc.2017.204. Epub 2017 Jul 6. Br J Cancer. 2017. PMID: 28683467 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,551 results

Search Page

Filters